Bank of America
SQZ

Bank of America’s SQZ Biotechnologies Company SQZ Stock Holding History

Bank of America’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,268
Closed -$342 – 8159
2023
Q2 		$342 Sell
1,268
-2,993
-70% -$1.7K ﹤0.01% 7350
2023
Q1 		$2.39K Sell
4,261
-10,006
-70% -$7.37K ﹤0.01% 7194
2022
Q4 		$10.6K Sell
14,267
-8,369
-37% -$18.3K ﹤0.01% 6905
2022
Q3 		$51K Buy
22,636
+32
+0.1% +$96 ﹤0.01% 6675
2022
Q2 		$72K Sell
22,604
-8,370
-27% -$30.1K ﹤0.01% 6655
2022
Q1 		$149K Sell
30,974
-6,568
-17% -$41.7K ﹤0.01% 6637
2021
Q4 		$335K Buy
37,542
+5,029
+15% +$61.6K ﹤0.01% 6170
2021
Q3 		$469K Sell
32,513
-1,651
-5% -$22.4K ﹤0.01% 5692
2021
Q2 		$494K Buy
34,164
+5,606
+20% +$73.2K ﹤0.01% 5440
2021
Q1 		$391K Buy
28,558
+25,613
+870% +$520K ﹤0.01% 5566
2020
Q4 		$86K Buy
+2,945
New +$75.2K ﹤0.01% 6063

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America's SQZ Position: Q3 2023 in Review

Bank of America sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 1,268 shares — an estimated $342 sold.

Bank of America first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $494K in Q2 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Bank of America reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 1,268 SQZ Biotechnologies Company shares in Q3 2023, an estimated $342.
  • Bank of America first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Bank of America's SQZ Biotechnologies Company position peaked at $494K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.